DEST — Destiny Pharma Share News
0.000.00%
- £3.83m
- -£2.55m
REG - Destiny Pharma PLC - Price Monitoring Extension
AnnouncementREG - Destiny Pharma PLC - Price Monitoring Extension
AnnouncementREG - Destiny Pharma PLC - Exercise of Options and Total Voting Rights
AnnouncementRCS - Destiny Pharma PLC - US Center for Disease Control review paper
AnnouncementREG - Destiny Pharma PLC - Second Price Monitoring Extn
AnnouncementREG - Destiny Pharma PLC - Price Monitoring Extension
AnnouncementREG - Destiny Pharma PLC - Year End Trading Update
AnnouncementREG - Destiny Pharma PLC - XF-73 Nasal final Phase 3 development plans
AnnouncementRCS - Destiny Pharma PLC - FDA/CDC highlight need for infection preventions
AnnouncementREG - Destiny Pharma PLC - Director Disclosure
AnnouncementREG - Destiny Pharma PLC - Appointment of Corporate Broker
AnnouncementREG - Destiny Pharma PLC - Director Shareholding Amendment
AnnouncementREG - Destiny Pharma PLC - XF-73 advances to clinically enabling safety study
AnnouncementREG - Destiny Pharma PLC - Price Monitoring Extension
AnnouncementREG - Destiny Pharma PLC - Second Price Monitoring Extn
AnnouncementREG - Destiny Pharma PLC - Notice of R&D Update Meeting
AnnouncementREG - Destiny Pharma PLC - Interim results for six months ended 30 June 2022
AnnouncementREG - Destiny Pharma PLC - Positive update from EMA on NTCD-M3 Phase 3 plans
AnnouncementRCS - Destiny Pharma PLC - Presenting at HC Wainwright Investment Conference
Announcement